Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Head & Neck 1Gastrointestinal 1

Conditions

Sarcoma 6Colorectal Neoplasms 6Neoplasm Metastasis 4Head and Neck Neoplasms 4Esophageal Neoplasms 4Stomach Neoplasms 3Rectal Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Gastrointestinal Stromal Tumors 2Chondrosarcoma 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Carcinoma 2Urinary Bladder Neoplasms 1Tracheal Neoplasms 1Thyroid Neoplasms 1Solitary Pulmonary Nodule 1Sarcoma, Ewing 1Sarcoma, Alveolar Soft Part 1Pulmonary Sclerosing Hemangioma 1Prostatic Neoplasms 1Phyllodes Tumor 1Parathyroid Neoplasms 1Pancoast Syndrome 1Ovarian Neoplasms 1Otorhinolaryngologic Neoplasms 1Osteosarcoma 1Myxosarcoma 1Myosarcoma 1

Interventions

Doxorubicin 6Ifosfamide 5Radiotherapy 4pazopanib 3cediranib 3atezolizumab 3Sunitinib 3selinexor 2perifosine 2pembrolizumab 2Trabectedin 2Specimen Handling 2Loperamide 2Gemcitabine 2Filgrastim 2Dacarbazine 2Cisplatin 2Biopsy 2Bevacizumab 2trifluridine tipiracil drug combination 1spartalizumab 1sargramostim 1romidepsin 1lentiviral minigene vaccine of COVID-19 coronavirus 1ixazomib 1indolepropanol phosphate 1futibatinib 1fludarabine 1cabozantinib 1brostallicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Alveolar Soft Part × Fluorouracil × Sarcoma × Clear all
NCT04999761 2024-09-25

AB122 Platform Study

Taiho Pharmaceutical Co., Ltd.

Phase 1 Recruiting
917 enrolled
GastrointestinalHead & NeckSarcomaThoracic

Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Stomach Neoplasms, Colorectal Neoplasms, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡